ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
8 209,28
0,00%
Dow Jones
39 431,51
-0,21%
DAX
18 742,22
-0,08%
Brent Oil
83,195
-0,02%
Bitcoin
61 707,66
-1,90%
Registration Strip Icon for discussion Inscrivez-vous pour interagir sur nos forums actifs pour discuter avec des investisseurs aux idées similaires.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Syneron Medical Ltd. - Ordinary Shares (ELOS)

  7. Syneron Medical Ltd. - Ordinary Shares (ELOS) Actualités

ELOS

Syneron Medical Ltd. - Ordinary Shares (ELOS)

Syneron Medical Ltd. - Ordinary Shares
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:ELOS
DateHeureSourceTitreSymboleSociété
01/08/201715h49Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:ELOSSyneron Medical Ltd. - Ordinary Shares
27/07/201715h01Edgar (US Regulatory)Termination of Registration of a Class of Security Under Section 12(g) (15-12g)NASDAQ:ELOSSyneron Medical Ltd. - Ordinary Shares
17/07/201716h57Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:ELOSSyneron Medical Ltd. - Ordinary Shares
17/07/201714h51Edgar (US Regulatory)(25-NSE)NASDAQ:ELOSSyneron Medical Ltd. - Ordinary Shares
17/07/201713h46Edgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:ELOSSyneron Medical Ltd. - Ordinary Shares
17/07/201713h30PR Newswire (US)Syneron Candela Completes Previously Announced Transaction with Funds Advised by Apax Partners and Becomes a Private CompanyNASDAQ:ELOSSyneron Medical Ltd. - Ordinary Shares
07/07/201717h55Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:ELOSSyneron Medical Ltd. - Ordinary Shares
15/06/201715h22PR Newswire (US)Syneron Candela Announces Shareholder Approval of Proposed Acquisition by Funds Advised by Apax PartnersNASDAQ:ELOSSyneron Medical Ltd. - Ordinary Shares
23/05/201714h37Edgar (US Regulatory)Specialized Disclosure Report (sd)NASDAQ:ELOSSyneron Medical Ltd. - Ordinary Shares
17/05/201723h00PR Newswire (US)Syneron Medical Reports First Quarter 2017 Revenue of $66.9 MillionNASDAQ:ELOSSyneron Medical Ltd. - Ordinary Shares
10/05/201712h13Edgar (US Regulatory)Statement of Beneficial Ownership (sc 13d)NASDAQ:ELOSSyneron Medical Ltd. - Ordinary Shares
10/05/201712h00PR Newswire (US)Syneron Candela Announces End of Go-Shop PeriodNASDAQ:ELOSSyneron Medical Ltd. - Ordinary Shares
03/04/201718h31Edgar (US Regulatory)Confidential Treatment Order (ct Order)NASDAQ:ELOSSyneron Medical Ltd. - Ordinary Shares
27/03/201710h00PR Newswire (US)Syneron Candela Announces CE Mark for CO2RE® IntimaNASDAQ:ELOSSyneron Medical Ltd. - Ordinary Shares
23/03/201721h10PR Newswire (US)Syneron Medical Ltd. Announces Availability of its Annual Report on Form 20-F through its WebsiteNASDAQ:ELOSSyneron Medical Ltd. - Ordinary Shares
23/03/201720h43Edgar (US Regulatory)Annual and Transition Report (foreign Private Issuer) (20-f)NASDAQ:ELOSSyneron Medical Ltd. - Ordinary Shares
20/03/201721h07Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ELOSSyneron Medical Ltd. - Ordinary Shares
01/03/201721h05PR Newswire (US)Syneron Candela Announces New Technology and Indications at the 2017 American Academy of Dermatology (AAD) Annual MeetingNASDAQ:ELOSSyneron Medical Ltd. - Ordinary Shares
15/02/201713h00PR Newswire (US)Syneron Medical Reports Fourth Quarter 2016 Revenue of $82.9 Million and Full Year 2016 Revenue $298.1 MillionNASDAQ:ELOSSyneron Medical Ltd. - Ordinary Shares
13/02/201715h00PR Newswire (US)Syneron Medical to Participate in Leerink Partners 6th Annual Global Healthcare ConferenceNASDAQ:ELOSSyneron Medical Ltd. - Ordinary Shares
07/02/201715h00GlobeNewswire Inc.Sientra Appoints Aesthetic Industry Leader Philippe A. Schaison to Board of DirectorsNASDAQ:ELOSSyneron Medical Ltd. - Ordinary Shares
31/01/201722h05PR Newswire (US)Syneron Medical Strengthens Senior Management Team with Appointment of Chief Human Resources OfficerNASDAQ:ELOSSyneron Medical Ltd. - Ordinary Shares
30/01/201715h00PR Newswire (US)Syneron Medical to Report Fourth Quarter and Full Year 2016 Financial Results on February 15, 2017NASDAQ:ELOSSyneron Medical Ltd. - Ordinary Shares
11/11/201622h00PR Newswire (US)Syneron Medical to Participate in the Canaccord Genuity Medical Technologies and Diagnostics ForumNASDAQ:ELOSSyneron Medical Ltd. - Ordinary Shares
09/11/201613h00PR Newswire (US)Syneron Medical Reports Third Quarter 2016 Revenue of $71.5 MillionNASDAQ:ELOSSyneron Medical Ltd. - Ordinary Shares
08/11/201615h00PR Newswire (US)Syneron Candela Announces FDA Clearance Of Profound™ SubQ To Improve The Appearance Of Cellulite, As Supported By Long Term...NASDAQ:ELOSSyneron Medical Ltd. - Ordinary Shares
17/10/201621h09Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:ELOSSyneron Medical Ltd. - Ordinary Shares
17/10/201613h00PR Newswire (US)Syneron Medical Strengthens Senior Management and Announces Preliminary Third Quarter 2016 RevenueNASDAQ:ELOSSyneron Medical Ltd. - Ordinary Shares
08/09/201622h01Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:ELOSSyneron Medical Ltd. - Ordinary Shares
04/08/201613h00PR Newswire (US)Syneron Medical Reports Second Quarter 2016 Revenue of $75.0 Million and Non-GAAP EPS of $0.09NASDAQ:ELOSSyneron Medical Ltd. - Ordinary Shares
 Showing the most relevant articles for your search:NASDAQ:ELOS

Dernières Valeurs Consultées

NASDAQ
GOOGL
Alphabet
COIN
BTCUSD
Bitcoin
EU
LR
Legrand
NASDAQ
AAPL
Apple
EU
AI
Air Liquide
EU
ORA
Orange
EU
ACA
Credit Agricole
NYSE
KO
Coca Cola
EU
ML
Michelin
EU
PX1
CAC 40
EU
EN
Bouygues
EU
GLE
Societe Generale
EU
PX4
SBF 120
EU
BEL20
Bel 20
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés